Evaluation of the efficacy of immunochemotherapy during initial and continuation period with regard to survival and possibility to obtain BMT
| . | All patients (n = 113) . | Familial cases (n = 25) . |
|---|---|---|
| Patients admitted to BMT + patients alive without BMT | 65 + 23 (78%) | 20 + 0 (80%) |
| Patients dead during initial/ continuation therapy3-150 | 25 (22%) | 5 (20%) |
| . | All patients (n = 113) . | Familial cases (n = 25) . |
|---|---|---|
| Patients admitted to BMT + patients alive without BMT | 65 + 23 (78%) | 20 + 0 (80%) |
| Patients dead during initial/ continuation therapy3-150 | 25 (22%) | 5 (20%) |
Five of these patients died more than 6 months after onset of therapy (one with a positive family history).